ID
CVS icon

Integral Derivatives’s CVS Health CVS Stock Holding History

Integral Derivatives’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$230K Sell
3,700
-13,000
-78% -$933K 0.01% 581
2017
Q4 		$1.21M Buy
16,700
+9,600
+135% +$698K 0.02% 428
2017
Q3 		$577K Buy
7,100
+300
+4% +$23.7K 0.01% 684
2017
Q2 		$547K Sell
6,800
-12,600
-65% -$995K 0.01% 682
2017
Q1 		$1.52M Buy
19,400
+3,000
+18% +$240K 0.03% 391
2016
Q4 		$1.29M Buy
16,400
+13,100
+397% +$1.06M 0.02% 440
2016
Q3 		$294K Sell
3,300
-1,800
-35% -$170K 0.01% 789
2016
Q2 		$488K Buy
5,100
+3,100
+155% +$309K 0.01% 600
2016
Q1 		$207K Buy
+2,000
New +$194K 0.01% 741
2015
Q4 		– Sell
-2,500
Closed -$241K – 1091
2015
Q3 		$241K Sell
2,500
-2,500
-50% -$263K 0.01% 925
2015
Q2 		$524K Sell
5,000
-5,700
-53% -$582K 0.01% 705
2015
Q1 		$1.1M Sell
10,700
-14,300
-57% -$1.45M 0.02% 479
2014
Q4 		$2.41M Buy
+25,000
New +$2.2M 0.04% 376
2014
Q2 		– Sell
-7,900
Closed -$591K – 1367
2014
Q1 		$591K Buy
7,900
+4,900
+163% +$346K 0.01% 835
2013
Q4 		$215K Buy
+3,000
New +$193K ﹤0.01% 1334

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Integral Derivatives's CVS Position: Q1 2018 in Review

Integral Derivatives reduced its CVS Health (CVS) stake by 31% in Q1 2018, selling an estimated $133K and leaving 4,146 shares worth $258K. The position accounts for 0.01% of the portfolio, ranked #541.

Integral Derivatives first reported a position in CVS in Q1 2015 and has held it in 9 quarters since. The position peaked at $3.07M in Q2 2017. 1,549 funds tracked by Wall St. Rank hold CVS as of Q1 2018.

  • Integral Derivatives held 4,146 shares of CVS Health worth $258K as of Q1 2018.
  • Integral Derivatives sold 1,850 CVS Health shares in Q1 2018, an estimated $133K.
  • CVS Health made up 0.01% of Integral Derivatives's portfolio in Q1 2018, its #541 holding.
  • Integral Derivatives first reported a position in CVS Health in Q1 2015 and has held it in 9 quarters since.
  • Integral Derivatives's CVS Health position peaked at $3.07M in Q2 2017.
  • 1,549 funds tracked by Wall St. Rank held CVS Health as of Q1 2018.

Based on Integral Derivatives's 13F filing for Q1 2018, filed 19 Apr 2018.